4//SEC Filing
Saad Mark E 4
Accession 0001209191-22-034826
CIK 0001579428other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:08 PM ET
Size
5.3 KB
Accession
0001209191-22-034826
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-03+16,976→ 16,976 totalExercise: $25.53From: 2023-06-03Exp: 2032-06-03→ Common Stock (16,976 underlying)
Footnotes (1)
- [F1]The option vests in full on the one-year anniversary of the date of grant, June 3, 2023.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001295913
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:08 PM ET
- Size
- 5.3 KB